Asset Details
Do you wish to reserve the book?
Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling
Do you wish to request the book?
Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling
2014
Overview
When growing up, the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of drugs change, which may alter the effect of drugs. To ensure optimal drug efficacy and safety in paediatric care, PK and PD relationships of drugs need to be explored in children. This article presents an outline on performing a population PK/PD study and translating these results into rational dosing regimens, with the development and prospective evaluation of PK/PD derived evidence-based dosing regimen being discussed. Examples on amikacin, morphine and busulfan are provided, showing how PK(/PD) modelling not only led to optimization and individualization in paediatric clinical care for the specific drugs but also to insight in maturation of organ systems involved. It is shown that the latter results can subsequently be used as a basis for dosing of other drugs eliminated through the same pathway. Ultimately, these efforts should lead to predictable drug efficacy and safety across all age groups.
Publisher
BMJ Publishing Group,BMJ Publishing Group LTD
Subject
Alkylating Agents - administration & dosage
/ Alkylating Agents - pharmacokinetics
/ Amikacin - administration & dosage
/ Analgesics, Opioid - administration & dosage
/ Analgesics, Opioid - pharmacokinetics
/ Anti-Bacterial Agents - pharmacokinetics
/ Biological and medical sciences
/ Busulfan - administration & dosage
/ Child
/ Dose-Response Relationship, Drug
/ Evidence
/ Humans
/ Morphine - administration & dosage
/ Neonates
/ Patients
/ Profiles
/ Public health. Hygiene-occupational medicine
/ Sampling
